Keona Holliday, PA
Orthopaedic Surgery · Largo, MDNPI 1205348893
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Amgen at 42.1% of the total. That places this record below the midpoint for orthopaedic surgery clinicians in MD, where the typical reported total is $2,738.
Across 24 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$231
- Radius Health, Inc.$57
- Eisai Inc.$32
- Genentech USA, Inc.$28
- UCB, Inc.$27
- Averitas Pharma Inc.$25
- plus $148 from 8 others
What the payments were for
- Food & beverage$548100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $231 |
| Radius Health, Inc. | 3 | $57 |
| Eisai Inc. | 2 | $32 |
| Genentech USA, Inc. | 1 | $28 |
| UCB, Inc. | 1 | $27 |
| Averitas Pharma Inc. | 1 | $25 |
| Vertos Medical, Inc. | 1 | $24 |
| Intrinsic Therapeutics | 1 | $19 |
| Bioventus LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Acumed LLC | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
How this compares
$548 in reported general payments places this provider in the 25th percentile of 378 orthopaedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Largo
- Mark MyersonBaltimore$10.5M
- David DaluryTowson$7.6M
- Anand MurthiBaltimore$3.7M
- Timothy CoddTowson$3.6M
- Khaled KebaishBaltimore$3M
- Michael AinLutherville$1.6M
- Shawn StandardBaltimore$1.4M
- Hamid HassanzadehBethesda$1.1M
- Paul SponsellerBaltimore$958K
- Paul TortolaniTowson$812K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.